PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 35 results · Data & Publications · Oncology  · Clear
🔒 Subscribers only
AUTH/3085/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Biogen
The PMCPA Director opened a complaint (under Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted results to the EU Clinical Trials Register (EUCTR) with…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3080/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Takeda
The PMCPA Director opened a complaint (under Paragraph 5.1 of the Constitution and Procedure) after a BMJ paper (Goldacre et al, published 12 Sept 2018) assessed whether sponsors posted due results…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3078/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Amgen
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3084/9/18
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
The PMCPA Director took up a complaint (Paragraph 5.1) after a BMJ paper (Goldacre et al, 12 Sept 2018) assessed whether sponsors posted due results to the EU Clinical Trials Register (EUCTR) by th…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3000/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A case was brought by the PMCPA Director against Roche.The subject matter related to clinical trial disclosure for Gazyvaro.The case was assessed under the 2016 ABPI Code of Practice.
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2985/10/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sun Pharma
A lead cancer pharmacist complained about an email promotion for Sun Pharma’s gemcitabine 10mg/ml ready-to-administer (RTA) infusion bags (ref SUNUK031), promoted as “The Only Licensed Ready-To…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2998/12/17
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Lilly
A matter was raised by the PMCPA Director concerning clinical trial disclosure relating to Cyramza.The case was considered under the ABPI Code of Practice (Applicable Code year: 2016).
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2908/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bayer
A CMRO transparency study (published online 25 Nov 2016) assessed whether results of company-sponsored trials linked to EMA 2013 approvals were disclosed within 12 months and by 31 Jul 2015.The PMC…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2898/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
The PMCPA Director opened a complaint after a CMRO transparency study (published 25 Nov 2016) suggested Roche had not disclosed one evaluable trial result within the required timeframe for Kadcyla …
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2895/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Boehringer Ingelheim
A complaint was brought by the Director against Boehringer Ingelheim.The subject matter related to clinical trial disclosure for Giotrif.Complaint received: 06 December 2016.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2899/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Aegerion
A matter was raised by the PMCPA Director regarding clinical trial disclosure relating to Lojuxta.The case was considered under the PMCPA complaints process.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2900/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Sanofi
The PMCPA Director raised a complaint against Sanofi concerning clinical trial disclosure relating to Lyxumia and Zaltrap.The matter was considered under case numbers AUTH/2900/11/16 and AUTH/2910/…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2909/11/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Astellas UK
The Director raised a complaint against Astellas UK.The issue related to clinical trial disclosure concerning Xtandi.The case was recorded as completed on the same date it was received.
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2872/9/16
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Lilly
A consultant oncologist and a pharmacist complained about the 8th edition (2014) of Lilly’s Handbook of Systemic Treatments for Cancer.They alleged the handbook was not up to date and therefore m…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2771/5/15
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Eisai
A complaint was made by the PMCPA Director under Paragraph 5.1 against Eisai.The subject matter related to clinical trial disclosure for Dacogen.The matter was reviewed and determined to be outwith…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2768/5/15
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A complaint was brought by the PMCPA Director under Paragraph 5.1 against Roche.The subject matter related to clinical trial disclosure for Zelboraf.The case was assessed under the 2015 ABPI Code o…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2764/5/15
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Janssen
Case AUTH/2764/5/15 was a Paragraph 5.1/Director matter involving Janssen.The issue related to clinical trial disclosure for Dacogen.The PMCPA recorded the outcome as outwith the scope of the Code.
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2686/1/14
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol
A member of the public made a complaint about Bristol-Myers Squibb relating to clinical trial disclosure for Javlor.The matter was considered under the ABPI Code of Practice (applicable Code year: …
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2654/11/13
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
An anonymous, contactable member of the public complained about a published ABPI-funded study on clinical trial transparency (published in Current Medical Research & Opinion, 11 Nov 2013).The s…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2675/11/13
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Eisai
A member of the public made a complaint about clinical trial disclosure relating to Halaven.The complaint was considered under the 2012 ABPI Code of Practice.The PMCPA determined the issue was outw…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2501/4/12
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Meda
ALK-Abelló complained about a Meda booklet titled ‘The Case for Epipen (Adrenaline) Auto-Injector’ (ref UK/EPI/11/0053d).Meda sent the booklet to pharmacy leads in senior roles within primary …
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2387/2/11
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
ALK-Abelló
A pharmacist (consultant to Lincoln Medical, which marketed Anapen) complained about ALK-Abelló’s formulary pack (ref 569AD) and formulary template (ref 584AD) for Jext (adrenaline auto-injector…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2405/5/11
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Meda v ALK-Abelló (Jext leavepiece)
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2391/2/11
Data & Publications Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
Takeda complained about a letter from AstraZeneca headed “Zoladex (goserelin) price reduction from 1st October 2010” sent to NHS budgetary stakeholders and used with appropriate health professi…
Clauses: NONE
2011 🔒 Subscribe
1 2 Next → Page 1 of 2 — 35 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews